These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37766247)

  • 1. Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo.
    von Beck T; Mena Hernandez L; Zhou H; Floyd K; Suthar MS; Skolnick J; Jacob J
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Otter CJ; Bracci N; Parenti NA; Ye C; Asthana A; Blomqvist EK; Tan LH; Pfannenstiel JJ; Jackson N; Fehr AR; Silverman RH; Burke JM; Cohen NA; Martinez-Sobrido L; Weiss SR
    Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320194121. PubMed ID: 38568967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
    Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
    J Virol; 2021 May; 95(12):. PubMed ID: 33789998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication.
    Gao B; Gong X; Fang S; Weng W; Wang H; Chu H; Sun Y; Meng C; Tan L; Song C; Qiu X; Liu W; Forlenza M; Ding C; Liao Y
    PLoS Pathog; 2021 Feb; 17(2):e1008690. PubMed ID: 33635931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flipped over U: structural basis for dsRNA cleavage by the SARS-CoV-2 endoribonuclease.
    Frazier MN; Wilson IM; Krahn JM; Butay KJ; Dillard LB; Borgnia MJ; Stanley RE
    Nucleic Acids Res; 2022 Aug; 50(14):8290-8301. PubMed ID: 35801916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.
    Yang CW; Hsu HY; Lee YZ; Jan JT; Chang SY; Lin YL; Yang RB; Chao TL; Liang JJ; Lin SJ; Liao CC; Chang CS; Sytwu HK; Hung MS; Chen CT; Lee SJ
    Biochem Pharmacol; 2023 Sep; 215():115688. PubMed ID: 37481137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
    Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
    Shalayel MH; Al-Mazaideh GM; Aladaileh SH; Al-Swailmi FK; Al-Thiabat MG
    Pak J Pharm Sci; 2020 Sep; 33(5):2179-2186. PubMed ID: 33824127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants.
    Wilson IM; Frazier MN; Li JL; Randall TA; Stanley RE
    J Mol Biol; 2022 Oct; 434(20):167796. PubMed ID: 35995266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.
    Hong S; Seo SH; Woo SJ; Kwon Y; Song M; Ha NC
    J Agric Food Chem; 2021 Jun; 69(21):5948-5954. PubMed ID: 34015930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Biochemical Characterization of Endoribonuclease Nsp15 Encoded by Middle East Respiratory Syndrome Coronavirus.
    Zhang L; Li L; Yan L; Ming Z; Jia Z; Lou Z; Rao Z
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30135128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Induced Primary Biles Inhibit SARS-CoV-2 Endoribonuclease Nsp15 Activity in Mouse Gut.
    Ma Y; Luo M; Deng Y; Yang X; Wang X; Chen G; Qin Z; Deng Y; Nan M; Chen Y; Wang P; Wei H; Han L; Fang X; Liu Z
    Front Cell Infect Microbiol; 2022; 12():896504. PubMed ID: 35967852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
    Otter CJ; Bracci N; Parenti NA; Ye C; Tan LH; Asthana A; Pfannenstiel JJ; Jackson N; Fehr AR; Silverman RH; Cohen NA; Martinez-Sobrido L; Weiss SR
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coronavirus nsp15 endoribonuclease: A puzzling protein and pertinent antiviral drug target.
    Van Loy B; Stevaert A; Naesens L
    Antiviral Res; 2024 Aug; 228():105921. PubMed ID: 38825019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
    Keshavarz Valian N; Pourakbari B; Asna Ashari K; Hosseinpour Sadeghi R; Mahmoudi S
    J Med Virol; 2022 Apr; 94(4):1450-1456. PubMed ID: 34786736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
    Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
    Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.